United States· US:51655-680_4950c3d6-8a7b-8e8f-e063-6294a90a015c
Citalopram
A citalopram product containing citalopram hydrobromide, registered in United States by Northwind Health Company, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Citalopram is registered in 18 of 19 countries.
Countries holding a registration under ATC N06AB04 (citalopram), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Citalopram · ATC N06AB04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of citalopram costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.18 in France to $1.01 in Switzerland — a ×5.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Citalopram · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.01
- IT Italy$0.22
- ES Spain$0.21
- FR France$0.18
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CITALOPRAM HYDROBROMIDE
- Manufacturer
- Northwind Health Company, LLC
- Country
- United States (US)
- ATC code
- N06AB04
- ATC class
- Citalopram
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11516556802690 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-680-26)
- ndc11516556805230 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-680-52)
- ndc1151655-680-26
- ndc1151655-680-52
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
628 interactions on record for citalopram.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Citalopram · interactions on record
628 records
- 147 severe
- 201 moderate
- 26 minor
- 183 info
Most severe, free to view
- CimetidineA02BA01severe
- OmeprazoleA02BC01severe
- LansoprazoleA02BC03severe
- EsomeprazoleA02BC05severe
71 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5f3b842-9275-484f-ac0b-67cf1d08a4ad GET /v1/drugs/f5f3b842-9275-484f-ac0b-67cf1d08a4ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20",
"substance": "CITALOPRAM HYDROBROMIDE",
"productndc": "51655-680",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA077031",
"marketing_category": "ANDA"
}See everything about citalopram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.